SCHEMBL796260

SCHEMBL796260

CC(=O)OCC1OC(OC(C)=O)C(C)C(C)C1OC1OC2COC(c3ccccc3)OC2C(C)C1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ PAX8 Q06710 1/20 0.37
▸ PRKCA P17252 1/20 0.37
▸ AKT1 P31749 1/20 0.37
▸ PTK2 Q05397 1/20 0.37
▸ CYP2D6 P10635 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ P4HB P07237 1/20 0.35
▸ PDIA4 P13667 1/20 0.35
▸ PDIA3 P30101 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16186744 0.91 L3MBTL1 (0.45) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL15083009 0.85 TSHR (0.52) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL16186745 0.84 L3MBTL1 (0.37) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL16715898 0.84 KMT2A (0.55) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL23591488 0.83 TSHR (0.56) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL25502819 0.80 L3MBTL1 (0.55) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL25502843 0.80 L3MBTL1 (0.55) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL17549065 0.78 L3MBTL1 (0.35) TSHRL3MBTL1KMT2AMEN1
SCHEMBL14329035 0.78 TSHR (0.43) TSHRL3MBTL1LMNAKMT2AMEN1
SCHEMBL12551924 0.77 L3MBTL1 (0.38) TSHRL3MBTL1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034844-B2 6′-sialyllactose salts and process for their synthesis and for the synthesis of other alpha-sialyloligosaccharides INALCO S.P.A. (IT) 2015-05-19 — — US disclosed
US-20120071441-A1 6'-SIALYLLACTOSE SALTS AND PROCESS FOR THEIR SYNTHESIS AND FOR THE SYNTHESIS OF OTHER ALPHA-SIALYLOLIGOSACCHARIDES INALCO S.P.A. (IT) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071441-A1 6'-SIALYLLACTOSE SALTS AND PROCESS FOR THEIR SYNTHESIS AND FOR THE SYNTHESIS OF OTHER ALPHA-SIALYLOLIGOSACCHARIDES ST6GAL1, FUT6, ST3GAL3 TSHR 1744/4885L3MBTL1 3410/4885LMNA 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback